Psychedelics show promise for mental health disorders

Psychedelics Show Promise for Mental Health Disorders

Psychedelics Show Promise for Mental Health Disorders Until recently, psychedelics, specifically psilocin from mushrooms and lysergic acid diethylamide (LSD), were limited to recreational use with no medicinal benefit. Currently, psychedelics are showing promise in clinical trials as therapeutic strategies for mental health disorders. While scientists understand the serotonergic modulation these drugs elicit in the brain […]

Closed-loop Neuromodulation in an Individual with Treatment-Resistant Depression

Closed-loop Neuromodulation in an Individual with Treatment-Resistant Depression

Closed-loop Neuromodulation in an Individual with Treatment-Resistant Depression Meriam-Webster defines depression as feelings of severe despondency and dejection, a severe medical condition in which a person feels very sad, hopeless, and unimportant and is often unable to live normally. In the end, the feelings of dejection and a hopeless existence leads many down the dark […]